126 related articles for article (PubMed ID: 1693469)
1. Immunopathology of adrenal and renal cortical tumors. Coordinated change in antigen expression is associated with neoplastic conversion in the adrenal cortex.
Cote RJ; Cordon-Cardo C; Reuter VE; Rosen PP
Am J Pathol; 1990 May; 136(5):1077-84. PubMed ID: 1693469
[TBL] [Abstract][Full Text] [Related]
2. Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma.
Wick MR; Cherwitz DL; McGlennen RC; Dehner LP
Am J Pathol; 1986 Feb; 122(2):343-52. PubMed ID: 2418689
[TBL] [Abstract][Full Text] [Related]
3. Adrenal cortical adenoma and adrenal metastasis of renal cell carcinoma: immunohistochemical and DNA ploidy analysis.
Kumar D; Kumar S
Mod Pathol; 1993 Jan; 6(1):36-41. PubMed ID: 7678935
[TBL] [Abstract][Full Text] [Related]
4. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
[TBL] [Abstract][Full Text] [Related]
5. Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins.
Holthöfer H; Miettinen A; Paasivuo R; Lehto VP; Linder E; Alfthan O; Virtanen I
Lab Invest; 1983 Sep; 49(3):317-26. PubMed ID: 6193332
[TBL] [Abstract][Full Text] [Related]
6. D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma.
Browning L; Bailey D; Parker A
J Clin Pathol; 2008 Mar; 61(3):293-6. PubMed ID: 17660332
[TBL] [Abstract][Full Text] [Related]
7. Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas. Distinction of two classes of renal cell tumors.
Pitz S; Moll R; Störkel S; Thoenes W
Lab Invest; 1987 Jun; 56(6):642-53. PubMed ID: 2439772
[TBL] [Abstract][Full Text] [Related]
8. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
Khurana KK; Truong LD; Verani RR
Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
Ozolek JA; Bastacky SI; Myers EN; Hunt JL
Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
[TBL] [Abstract][Full Text] [Related]
10. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration.
Fetsch PA; Powers CN; Zakowski MF; Abati A
Cancer; 1999 Jun; 87(3):168-72. PubMed ID: 10385449
[TBL] [Abstract][Full Text] [Related]
11. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.
Sim SJ; Ro JY; Ordonez NG; Park YW; Kee KH; Ayala AG
Mod Pathol; 1999 Apr; 12(4):351-5. PubMed ID: 10229498
[TBL] [Abstract][Full Text] [Related]
12. Immunofluorescence microscopic evaluation of the intermediate filament expression of the adrenal cortex and medulla and their tumors.
Miettinen M; Lehto VP; Virtanen I
Am J Pathol; 1985 Mar; 118(3):360-6. PubMed ID: 3883796
[TBL] [Abstract][Full Text] [Related]
13. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
14. Expression of intermediate filament proteins in thyroid gland and thyroid tumors.
Miettinen M; Franssila K; Lehto VP; Paasivuo R; Virtanen I
Lab Invest; 1984 Mar; 50(3):262-70. PubMed ID: 6199582
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin expression in adrenocortical neoplasia: an immunohistochemical and biochemical study with implications for the differential diagnosis of adrenocortical, hepatocellular, and renal cell carcinoma.
Gaffey MJ; Traweek ST; Mills SE; Travis WD; Lack EE; Medeiros LJ; Weiss LM
Hum Pathol; 1992 Feb; 23(2):144-53. PubMed ID: 1371262
[TBL] [Abstract][Full Text] [Related]
16. Blood group-related antigens in human kidney: modulation of Lewis determinants in renal cell carcinoma.
Cordon-Cardo C; Reuter VE; Finstad CL; Sheinfeld J; Lloyd KO; Fair WR; Melamed MR
Cancer Res; 1989 Jan; 49(1):212-8. PubMed ID: 2461798
[TBL] [Abstract][Full Text] [Related]
17. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Nitrofurantoin (CAS No. 67-20-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Sep; 341():1-218. PubMed ID: 12724784
[TBL] [Abstract][Full Text] [Related]
19. A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors.
Renshaw AA; Granter SR
Mod Pathol; 1998 Dec; 11(12):1160-4. PubMed ID: 9872645
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the microvessel network to the clonal and kinetic profiles of adrenal cortical proliferative lesions.
Diaz-Cano SJ; de Miguel M; Blanes A; Galera H; Wolfe HJ
Hum Pathol; 2001 Nov; 32(11):1232-9. PubMed ID: 11727263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
